Mann S W, Fuller G C, Rodil J V, Vidins E I
Gut. 1979 Oct;20(10):825-32. doi: 10.1136/gut.20.10.825.
Hepatic prolyl hydroxylase activity and collagen synthesis were measured in patients with alcoholic liver disease to determine the feasibility of using the enzyme prolyl hydroxylase as a marker of hepatic fibrogenesis. Alcoholic patients with liver histopathology consistent with normal, steatosis, alcoholic hepatitis, early cirrhosis, or advanced cirrhosis were analysed for liver prolyl hydroxylase activity and in vitro collagen synthesis. Prolyl hydroxylase activity and the rate of in vitro collagen synthesis were correlated when these parameters were measured in samples of the same liver biopsy. Mean prolyl hydroxylase activity was significantly raised in all groups of alcoholic patients with alcoholic liver disease, except those with steatosis, when compared with alcoholic patients with normal morphology. Alcoholic patients with early cirrhosis had enzyme activity (mean +/- SE: 1.367 +/-0.162 mU/mg protein) significantly raised over all other groups. Mean enzyme activity was less raised (0.985 +/- 0.097 mU/mg protein) in patients with advanced cirrhosis. The percentage of collagen synthesis in patients with early or advanced cirrhosis was also raised compared with alcoholic patients with normal morphology. Prolyl hydroxylase activity and the rate of collagen synthesis are significantly correlated (r=0.62). These findings suggest that hepatic prolyl hydroxylase activity is a useful indicator of hepatic fibrogenesis and its measurement on available liver biopsy tissue should be a potent diagnostic tool reflecting active fibrogenesis and predicting progression of alcoholic liverdisease.
对酒精性肝病患者的肝脏脯氨酰羟化酶活性和胶原蛋白合成进行了检测,以确定将脯氨酰羟化酶用作肝纤维化生成标志物的可行性。对肝脏组织病理学表现分别为正常、脂肪变性、酒精性肝炎、早期肝硬化或晚期肝硬化的酒精性肝病患者,分析其肝脏脯氨酰羟化酶活性和体外胶原蛋白合成情况。在同一份肝活检样本中检测这些参数时,脯氨酰羟化酶活性与体外胶原蛋白合成速率相关。与肝脏形态正常的酒精性肝病患者相比,除脂肪变性患者外,所有酒精性肝病患者组的平均脯氨酰羟化酶活性均显著升高。早期肝硬化酒精性肝病患者的酶活性(平均值±标准误:1.367±0.162 mU/mg蛋白)显著高于所有其他组。晚期肝硬化患者的平均酶活性升高幅度较小(0.985±0.097 mU/mg蛋白)。与肝脏形态正常的酒精性肝病患者相比,早期或晚期肝硬化患者的胶原蛋白合成百分比也有所升高。脯氨酰羟化酶活性与胶原蛋白合成速率显著相关(r=0.62)。这些发现表明,肝脏脯氨酰羟化酶活性是肝纤维化生成的一个有用指标,对可用肝活检组织进行该指标的检测应是反映活跃纤维化生成和预测酒精性肝病进展的有力诊断工具。